DIN 02490064 — ESPEROCT 500 UNIT
ESPEROCT is a powder for solution of Antihemophilic Factor VIII (Recombinant, B-Domain Truncated), PEGylated marketed by NOVO NORDISK CANADA INC. The full Antihemophilic Factor VIII (Recombinant, B-Domain Truncated), PEGylated monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02490064
- Brand name
- ESPEROCT
- Strength
- 500 UNIT
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- NOVO NORDISK CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Recombinant coagulation Factor VIII (glycoPEGylated)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Antihemophilic Factor VIII (Recombinant, B-Domain Truncated), PEGylated products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02490072 | ESPEROCT | 1000 UNIT | POWDER FOR SOLUTION | NOVO NORDISK CANADA INC | MARKETED |
| 02490099 | ESPEROCT | 2000 UNIT | POWDER FOR SOLUTION | NOVO NORDISK CANADA INC | MARKETED |
| 02490102 | ESPEROCT | 3000 UNIT | POWDER FOR SOLUTION | NOVO NORDISK CANADA INC | MARKETED |